Ultra‐mutated colorectal cancer patients with POLE driver mutations exhibit distinct clinical patterns

POLE mutations, which lead to an ultramutated phenotype in colorectal cancer (CRC), have been reported as a promising marker in immunotherapy. We performed sequencing of CRC cases in Zhejiang University (ZJU) and extracted obtainable data from recently published results, including The Cancer Genome...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Hanguang, Cai, Wen, Wu, Dehao, Hu, Wangxiong, Dong Wang, Li, Mao, Jianshan, Zheng, Shu, Ge, Weiting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826451/
https://www.ncbi.nlm.nih.gov/pubmed/33125191
http://dx.doi.org/10.1002/cam4.3579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826451/
https://www.ncbi.nlm.nih.gov/pubmed/33125191
http://dx.doi.org/10.1002/cam4.3579

Ejemplares similares